Screener
Veracyte VCYT Income Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $150.32M+15.5% | $139.07M+21.5% | $140.64M+18.5% | $131.87M+13.8% | $130.16M+13.8% | ||
| —— | —— | —— | —— | —— | ||
| $108.55M+20.9% | $101.16M+27.2% | $101.97M+29.5% | $91.28M+15.5% | $89.77M+15.2% | ||
| 72.2%+3.2pp | 72.7%+3.3pp | 72.5%+6.1pp | 69.2%+1.0pp | 69%+0.9pp | ||
| $29.44M+81.0% | $27.1M+52.9% | $20.85M+8.1% | $15.98M-9.1% | $16.26M-1.2% | ||
| $28.26M+11.6% | $27.16M+11.0% | $25.94M+4.5% | $24.46M+8.2% | $25.32M+4.5% | ||
| $27.44M-15.1% | $23.68M-30.0% | $17.37M-35.5% | $27.28M+6.0% | $32.33M+1.8% | ||
| —— | —— | —— | —— | —— | ||
| $85.57M-10.0% | $78.51M+2.5% | $64.78M-13.1% | $68.34M+2.0% | $95.04M+29.6% | ||
| $22.98M+536% | $22.65M+680% | $37.2M+791% | $22.95M+90.9% | -$5.27M-214% | ||
| 15.3%+19.3pp | 16.3%+13.7pp | 26.4%+22.9pp | 17.4%+7.0pp | -4%-8.1pp | ||
| $3.54M-45.6% | $7.33M+62.0% | $3.44M— | -$4.06M-184% | $6.52M+137% | ||
| $26.52M+2,022% | $29.97M+304% | $40.63M+1,080% | $18.89M+12.1% | $1.25M-83.0% | ||
| $1.03M-53.7% | $1.27M+233% | —— | -$248K-115% | $2.23M+37.1% | ||
| $25.49M+2,701% | $28.71M+307% | $41.15M+705% | $19.14M+26.3% | -$980K-117% | ||
| 17%+17.7pp | 20.6%+14.5pp | 29.3%+24.9pp | 14.5%+1.4pp | -0.8%-5.8pp | ||
| $0.31+3,200% | $0.35+289% | $0.50+733% | $0.24+26.3% | -$0.01-114% | ||
| $27.82M+12,487% | $28.08M+240% | $42.49M+307% | $28.21M+57.7% | $221K-97.9% | ||
| 18.5%+18.3pp | 20.2%+13.0pp | 30.2%+21.4pp | 21.4%+5.9pp | 0.2%-8.9pp | ||
| $22.98M+536% | $22.65M+680% | $37.2M+791% | $22.95M+90.9% | -$5.27M-214% |
FAQ
- What is Veracyte's revenue?
- Veracyte (VCYT) generated $561.9M in revenue over the trailing twelve months, up 17.3% year over year.
- Is Veracyte profitable?
- Veracyte reported $114.5M in net income over the trailing twelve months, a 20.4% net margin.
- What are Veracyte's profit margins?
- Gross margin is 71.7% and operating margin is 18.8%, with a 20.4% net margin.
- What is Veracyte's earnings per share?
- Veracyte's diluted EPS over the trailing twelve months is $1.40.
- Where does Veracyte's income statement data come from?
- Every line is extracted from Veracyte's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
